RFK Jr: Pills Not Pistols to Blame for America’s Mass Shooting Crisis

What Happened

In response to the recent school shooting in Minneapolis, Robert F. Kennedy Jr. is challenging the idea that stricter gun laws are the only solution to mass shootings. Instead of joining the renewed calls for firearm regulation, he described the pattern of mass violence as a national health crisis. He also said psychiatric medications may be a contributing factor.

Kennedy announced that he plans to direct the Department of Health and Human Services to study whether there is a connection between certain psychiatric drugs and acts of violence. The review would focus on medications that carry the highest level of safety warning from the Food and Drug Administration. These include antidepressants known as selective serotonin reuptake inhibitors, which are commonly prescribed to treat depression and anxiety.

According to Kennedy, these medications may play a role in a small but significant number of violent incidents. He said they deserve closer scrutiny by federal health authorities.

Why It Matters

Kennedy’s comments introduce a different angle into a national conversation that typically centers almost exclusively on firearms and the call for stricter gun control. Kennedy’s point is that guns have been a constant part of American society, but the rise in mass shootings is a more recent development. In his view, this means the cause could involve other factors, such as changes in mental health treatment and the widespread use of psychiatric medications.

The real big data play – Palantir’s 1,597% vs 32,481% company no one’s talking about

Anyone who invested in Palantir at IPO in 2020 could be sitting on nearly 1,600% gains right now.

But that great return is already in the past, and the stock is now one of the S&P 500’s most expensive.

But while Palantir was climbing on the back of your public information, another company was redefining big data.*

Mode Mobile has already delivered 32,481% revenue growth before even going public.

Mode has:

• 50M+ users

• $325M+ paid to users

• $75M in real revenue

• Nasdaq ticker secured for potential IPO

• Pre-IPO shares available for a limited time

Mode’s model pays users for their screen time and turns Big Tech’s free data mining play into a cash-generating engine for everyone.

Palantir now trades at 245× forward earnings, which means Wall Street has already priced in massive expectations.

But Mode? 

Still private. 

That means the market hasn’t had its say yet.

Right now, everyday investors (not just insiders) can get Mode shares at early-stage pricing.

When the Nasdaq ticker potentially goes live, that window could close fast. 

50,000+ shareholders have already invested in their recent oversubscribed round at $0.30/share.

Palantir’s moment has passed.

Mode’s may just be starting.

>>> See how to get Mode pre-IPO shares + bonus

His response in the wake of the shooting has sparked both interest and criticism. Many believe that examining the potential side effects of psychiatric drugs is a reasonable step, especially considering the growing number of Americans taking these medications. But detractors, including many in the medical community, warn that raising doubts about psychiatric treatment without clear evidence may spread fear or discourage people from seeking care.

While no scientific research has established a clear link between antidepressants and mass shootings, it is notable that most mass shooters have documented histories of mental illness. Many were on medication, had stopped taking it, or had never received treatment.

Some studies have reported rare cases of increased aggression or suicidal thoughts when certain medications are started or changed, especially in young people. However, these risks are already part of existing drug warnings and are generally considered manageable under medical supervision.

How It Affects Readers

Kennedy’s approach adds a layer of complexity to how people understand and discuss mass shootings. It encourages looking beyond gun access and considering how the health care system might play a role in identifying or missing warning signs. It may also prompt questions about how medications are prescribed and monitored, especially for children and teenagers.

If Kennedy’s plan is implemented and seen through, it could lead to new research and possibly new safety protocols related to psychiatric drugs. That could include stronger screening before prescriptions are issued, more frequent follow-ups with patients, or updated guidance for healthcare providers.

But there is a concern that his statements could contribute to the stigma around mental health treatment. Many individuals rely on these medications safely and effectively. Oversimplifying the risks could result in some avoiding treatment that would otherwise help them.

While Kennedy’s push does not provide a definitive answer, it does broaden the scope of the conversation. As public concern over both violence and mental health grows, his approach forces policymakers, researchers, and voters to consider whether current systems are missing something important.

*Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.

The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.

The gain figures are based on Palantir Technologies’ IPO in September 2020 and its share price as of August 2025, using adjusted closing data from Yahoo Finance.

In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. Mode Mobile has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here:https://www.sec.gov/Archives/edgar/data/1748441/000164117225025402/ex99.pdf